[1]Cormier JN, Vauthey JN.Biliary tract cancer[J].Curr OpinGastroenterology[J].2000, 16 (5) :437-443.
|
[2]石景森, 王炳煌.外科黄疸疾病诊断治疗学[M].北京:人民军医出版社, 2003:381-402.
|
[3]马幼平, 李恩山, 陈孝平, 等.肝门部胆管癌的诊治:附96例报告[J].中国普通外科杂志, 2008, 17 (8) :798-800.
|
[4]DeOliveira ML, Cunningham SC, Cameron JL, et al.Cholangiocarcinoma:thirty-one-year experience with 564patients at a single institution[J].Ann Surg, 2007, 245 (5) :755-762.
|
[5]黄志强.当代胆道外科学[M].上海:上海科学技术出版社, 1998:615-637.
|
[6]郑树国, 何振平, 董家鸿, 等.肝门部胆管癌149例临床分析[J].医学临床研究, 2005, 22 (10) :1369-1371.
|
[7]Clary B, Jarnigan W, Pitt H.Hilar cholangiocarcinoma[J].JGastrointest Surg, 2004, 8 (3) :298-302.
|
[8]Ingrid B, Kelvin H, Richard S, et al.Transcatheter arterialchemoembolization in unresectable cholangiocarcinoma:initial experience in a single institution[J].J Vasc IntervRadiol, 2005, 16 (3) :353-361.
|
[9]张宗利, 柴杰, 马德民, 等.肝门部胆管癌223例临床分析[J].中国现代普通外科进展, 2009, 12 (7) :570-572.
|
[10]Seyama Y, Makuuchi M.Current surgical treatment for bile ductcancer[J].World J Gastroenterol, 2007, 13 (10) :1505-1515.
|
[1] | Congying CHEN, Ruling ZHANG, Liang QIAO, Lungen LU, Hui ZHOU. A case of chronic gelatinous ascites caused by giant intraductal papillary mucinous neoplasm of the bile tract[J]. Journal of Clinical Hepatology, 2023, 39(1): 147-151. doi: 10.3969/j.issn.1001-5256.2023.01.022 |
[2] | Pinsheng HAN, Long YANG, Tao CUI, Yamin ZHANG. Role of tumor-associated macrophages in cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(2): 469-473. doi: 10.3969/j.issn.1001-5256.2023.02.035 |
[3] | Songsong FAN, Fang ZHANG, Lipeng YANG, Xuefeng CAO, Yanmin LU, Xingyuan ZHANG. Chronic cholangitis with interstitial mucinous degeneration misdiagnosed as cholangiocarcinoma: A case report[J]. Journal of Clinical Hepatology, 2022, 38(7): 1626-1628. doi: 10.3969/j.issn.1001-5256.2022.07.031 |
[4] | Shun CHEN, Jun WANG. Advances in tumor microenvironment and immunotherapy of Cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(10): 2428-2432. doi: 10.3969/j.issn.1001-5256.2022.10.044 |
[5] | Ying XU, Jia TANG, Qingyun HE, Huichao WU. Research advances in intraductal papillary mucinous neoplasm of the bile tract[J]. Journal of Clinical Hepatology, 2021, 37(12): 2981-2985. doi: 10.3969/j.issn.1001-5256.2021.12.052 |
[6] | Ziyue WANG, Daqun LIU, Jiaao YU, Jingxuan ZHANG, Guoyue LYU. A case of huge intrahepatic biliary papillomatosis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2651-2652. doi: 10.3969/j.issn.1001-5256.2021.11.034 |
[7] | DENG HaiMin, DUAN HuaXin. Current status of the research on targeted therapy for cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2020, 36(12): 2856-2859. doi: 10.3969/j.issn.1001-5256.2020.12.046 |
[8] | Wang ShiDong, Wang XiaoWei, Liu GuoHong, Tian ZiBin, Zhao QingXi. Research advances in intraductal papillary neoplasm of the bile duct[J]. Journal of Clinical Hepatology, 2020, 36(2): 476-480. doi: 10.3969/j.issn.1001-5256.2020.02.054 |
[9] | Yi Dan, Wang ShuPeng, Dong ShanShan, Ren XueKang, Niu ChunYuan, Liu SongYang. Biliary neuroendocrine carcinoma: A case report[J]. Journal of Clinical Hepatology, 2019, 35(11): 2551-2552. doi: 10.3969/j.issn.1001-5256.2019.11.034 |
[10] | Wu YanBin, Wang XueWen, Niu HongKai, Cheng Yu. Research advances in the role of protective autophagy in regulating vasculogenic mimicry formation in malignancies such as cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2019, 35(8): 1882-1884. doi: 10.3969/j.issn.1001-5256.2019.08.053 |
[11] | Yuan Bo, Li JianGong, Cheng Yu. Association between cholangiocarcinoma and Helicobacter pylori[J]. Journal of Clinical Hepatology, 2018, 34(2): 444-447. doi: 10.3969/j.issn.1001-5256.2018.02.050 |
[12] | Su LiHong, Zhu XinYu, Zhang LiaoYun. Diagnosis strategies for intrahepatic cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2017, 33(1): 180-183. doi: 10.3969/j.issn.1001-5256.2017.01.042 |
[13] | Fang Long, Fan YanHua. An excerpt of 2016 ESMO clinical practice guidelines for diagnosis, treatment and follow-up in biliary cancer[J]. Journal of Clinical Hepatology, 2017, 33(2): 238-243. doi: 10.3969/j.issn.1001-5256.2017.02.005 |
[14] | Li ZhaoXin, Ma WenCong, Zhang Ping. A case of intraductal papillary mucinous neoplasm with cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2017, 33(1): 169-170. doi: 10.3969/j.issn.1001-5256.2017.01.039 |
[15] | Yang ZhiGang, Cai YuHan. Four misdiagnosed cases of cholangiocarcinoma [J]. Journal of Clinical Hepatology, 2016, 32(5): 962-963. doi: 10.3969/j.issn.1001-5256.2016.05.037 |
[16] | Chinese Chapter of International Hepato-Pancreato-Biliary Association,Hepatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association. Diagnosis and treatment of cholangiocarcinoma: surgical expert consensus [J]. Journal of Clinical Hepatology, 2015, 31(1): 12-16. doi: 10.3969/j.issn.1001-5256.2015.01.003 |
[17] | Zhu Zhen, Cong WenMing. Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011[J]. Journal of Clinical Hepatology, 2013, 29(1): 42-44. |
[18] | Huang Bo, Zhao GuoZhong. Expressions of Annexin Ⅱ and Ki-6 in cholangiocarcinoma and their clinicopathological significance[J]. Journal of Clinical Hepatology, 2011, 27(2): 178-180+193. |